Form 4 for AVTX Avalo Therapeutics, Inc.
Accepted 2021-12-14 00:00:00 ET · period of report 2021-12-10 · accession 0001879785-21-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-14 | 2021-12-10 | AVTX | Wilkins H Jeffrey | Chief Medical Off | P - Purchase | $1.57 | +6,371 | 33.4K | +24% | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-10 | P | A | 6,371 | $1.57 | 33,373 | D | — | — | (F1) These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan. |